Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. k. 2012, 62 (1): 10-29.
Google Scholar
Feldman BJ, Feldman D: The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001, 1 (1): 34-45. 10.1038/35094009.
Article
CAS
PubMed
Google Scholar
Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008, 8 (10): 755-768. 10.1038/nrc2499.
Article
CAS
PubMed
Google Scholar
Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65 (23): 10946-10951. 10.1158/0008-5472.CAN-05-2018.
Article
CAS
PubMed
Google Scholar
Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, et al: Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 2006, 25 (12): 1696-1708. 10.1038/sj.onc.1209327.
Article
CAS
PubMed
Google Scholar
Mimeault M, Batra SK: Characterization of nonmalignant and malignant prostatic stem/progenitor cells by Hoechst side population method. Methods Mol Biol. 2009, 568: 139-149. 10.1007/978-1-59745-280-9_8.
Article
PubMed
Google Scholar
Fan X, Liu S, Su F, Pan Q, Lin T: Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Urol Oncol. 2012, 30 (3): 314-318. 10.1016/j.urolonc.2010.03.019.
Article
CAS
PubMed
Google Scholar
Rybak AP, He L, Kapoor A, Cutz JC, Tang D: Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochim Biophys Acta. 2011, 1813 (5): 683-694. 10.1016/j.bbamcr.2011.01.018.
Article
CAS
PubMed
Google Scholar
Lai EC: Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet. 2002, 30 (4): 363-364. 10.1038/ng865.
Article
CAS
PubMed
Google Scholar
Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 2006, 6 (11): 857-866. 10.1038/nrc1997.
Article
CAS
PubMed
Google Scholar
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, et al: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007, 131 (6): 1109-1123. 10.1016/j.cell.2007.10.054.
Article
CAS
PubMed
Google Scholar
Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et al: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011, 17 (2): 211-215. 10.1038/nm.2284.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL: MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis. 2012, Epub ahead of print
Google Scholar
Catto JW, Alcaraz A, Bjartell AS, De Vere WR, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, et al: MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011, 59 (5): 671-681. 10.1016/j.eururo.2011.01.044.
Article
CAS
PubMed
Google Scholar
Spahn M, Kneitz S, Scholz CJ, Stenger N, Rudiger T, Strobel P, Riedmiller H, Kneitz B: Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. International journal of cancer Journal international du cancer. 2010, 127 (2): 394-403.
CAS
PubMed
Google Scholar
Li T, Li D, Sha J, Sun P, Huang Y: MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun. 2009, 383 (3): 280-285. 10.1016/j.bbrc.2009.03.077.
Article
CAS
PubMed
Google Scholar
Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N, et al: miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol Cell Biochem. 2011, 350 (1–2): 207-213.
Article
CAS
PubMed
Google Scholar
Ru P, Steele R, Newhall P, Phillips NJ, Toth K, Ray RB: miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol Cancer Ther. 2012, 11 (5): 1166-1173. 10.1158/1535-7163.MCT-12-0100.
Article
CAS
PubMed
Google Scholar
Urtreger AJ, Werbajh SE, Verrecchia F, Mauviel A, Puricelli LI, Kornblihtt AR, Bal de Kier Joffe ED: Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential. Oncol Rep. 2006, 16 (6): 1403-1410.
CAS
PubMed
Google Scholar
Zhang X, Liu S, Hu T, He Y, Sun S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 2009, 50 (2): 490-499. 10.1002/hep.23008.
Article
CAS
PubMed
Google Scholar
Fan X, Ouyang N, Teng H, Yao H: Isolation and characterization of spheroid cells from the HT29 colon cancer cell line. Int J Colorectal Dis. 2011, 26 (10): 1279-1285. 10.1007/s00384-011-1248-y.
Article
PubMed
Google Scholar
Salvatori L, Caporuscio F, Verdina A, Starace G, Crispi S, Nicotra MR, Russo A, Calogero RA, Morgante E, Natali PG, et al: Cell-to-cell signaling influences the fate of prostate cancer stem cells and their potential to generate more aggressive tumors. PLoS One. 2012, 7 (2): e31467-10.1371/journal.pone.0031467.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu X, Zhang X, Dhakal IB, Beggs M, Kadlubar S, Luo D: Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells. BMC Cancer. 2012, 12: 29-10.1186/1471-2407-12-29.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lin T, Dong W, Huang J, Pan Q, Fan X, Zhang C, Huang L: MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol. 2009, 181 (3): 1372-1380. 10.1016/j.juro.2008.10.149.
Article
CAS
PubMed
Google Scholar
Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA: MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 2007, 26 (30): 4442-4452. 10.1038/sj.onc.1210228.
Article
CAS
PubMed
Google Scholar
Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007, 297 (17): 1901-1908. 10.1001/jama.297.17.1901.
Article
CAS
PubMed
Google Scholar
Koo S, Martin GS, Schulz KJ, Ronck M, Toussaint LG: Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines. BMC Cancer. 2012, 12: 143-10.1186/1471-2407-12-143.
Article
CAS
PubMed
PubMed Central
Google Scholar